Olin Corp. is underearning on depressed chlor-alkali prices. Hotchkis & Wiley's fund sees a multi-year supply tightening cycle that could drive a pricing recovery, with Olin as the swing producer capturing disproportionate upside.
Alpha Score of 33 reflects weak overall profile with poor momentum, moderate value, poor quality, moderate sentiment.
Olin Corp. has been the worst performer in the Hotchkis & Wiley Mid-Cap Value Fund this quarter. The fund's own second-quarter 2026 letter, however, lays out a detailed case for recovery.
The thesis revolves around North American chlor-alkali supply. Olin is the region's swing producer, and the fund expects a tightening multi-year supply outlook to lift prices and volumes from current depressed levels. "It is significantly underearning today due to below-normal commodity prices and demand," the letter said. "A tightening five-plus year supply/demand outlook in North American chlor-alkali could drive a pricing and volume recovery– and as the swing producer in the region, Olin could capture more than its share of that improvement."
The stock closed at $18.62 on August 3, down 10.22% over the past month and 2.05% over 52 weeks. Market capitalisation stands at $2.12 billion. The decline reflects easing Middle East tensions that will loosen near-term supply dynamics in commodity chemicals, the fund said.
Three structural supports underpin the fund's bet. Olin carries an investment-grade balance sheet, a shareholder-friendly capital allocation policy, and the recently announced merger of equals with Huntsman. The fund called that deal "strategically sound," saying it will reduce risk over the intermediate term through synergy capture and deleveraging.
Olin's Alpha Score sits at 33 out of 100, labelled Weak. The score suggests the market is pricing in current earnings weakness, not the forward recovery the fund is betting on. The sector is Basic Materials, and the stock page is here.
Forty-two hedge fund portfolios held Olin at the end of the first quarter, down from 46 in the prior quarter, according to database figures. The trimming aligns with the stock's recent underperformance. It also means less crowded positioning if the chlor-alkali cycle turns.
The timing risk is central to the thesis. The fund acknowledged that today's below-normal commodity prices and demand are the reason Olin is "significantly underearning." Recovery depends on supply tightening that plays out over five-plus years. Near-term headwinds from Middle East supply normalisation could keep the stock under pressure before that longer-term thesis takes hold.
The Winchester ammunition brand provides a non-commodity revenue stream. The bulk of the valuation story, however, sits on chlor-alkali margins. The Huntsman merger layers execution risk on top of cyclical exposure. For the fund's bet to pay off, both the commodity cycle and the deal integration need to cooperate.
Hotchkis & Wiley Mid-Cap Value Fund returned 4.74% in the second quarter, lagging the Russell Midcap Value Index's 13.4%. Technology and energy sector picks dragged, while healthcare stock selection contributed positively. Equity markets overall delivered strong returns, with the Russell Midcap Index rising 13.8% despite inflation concerns and a hawkish Federal Reserve.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.